JPMorgan cuts Hypera price target to R$28, maintains Overweight
JPMorgan lowered its price target for Hypera to R$28 from R$31 while maintaining its Overweight recommendation.
JPMorgan lowered its price target for Hypera to R$28 from R$31 while maintaining its Overweight recommendation.